Navigation Links
Reportlinker Adds Pharmaceutical Key Trends 2011 - Prescription Pharmaceutical Sales Overview
Date:4/28/2011

NEW YORK, April 28, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Pharmaceutical Key Trends 2011 - Prescription Pharmaceutical Sales Overview

http://www.reportlinker.com/p0460810/Pharmaceutical-Key-Trends-2011---Prescription-Pharmaceutical-Sales-Overview.html

Introduction

Prescription pharmaceutical sales in the world's major markets (US, France, Germany, Italy, Spain, the UK, Japan, Australia, Brazil, Russia, China and India) totaled $555bn in 2009, having grown by 6.3% during 2008–09, and at a compound annual growth rate (CAGR) of 5.6% between 2005 and 2009.

Features and benefits

* Examines the prescription pharmaceutical sales growth trends across the various different therapy areas

* Assesses the leading prescription pharmaceutical brands across the each of the 12 major pharma markets

* Profiles the leading multinational and domestic pharma companies operating in each of the 12 major pharma markets

* Analyzes the forecast sales according to lifecycle stage of drug, molecule type, source of drug, geographical market, therapy area and formulation

Highlights

The US prescription pharmaceutical market generated half (50.3%) of the sales of the 12 markets analyzed, with $279bn in 2009, with sales having grown by 5.0% (CAGR, 2005–09) and 5.5% (2008–09). However, future sales growth will be shaped by three key events: the US economic downturn, healthcare reform and the patent cliff.

Pharma is set to loose approximately $108bn in sales due to the patent cliff during 2010–15, while the industry is also feeling the affect of the recent global economic downturn. However, Pharma is implementing a number of strategies to drive sales and profitability going forward: product innovation, diversification and cost-containment.

Growth in the emerging markets is driven by their rapidly growing economies and populations; expansion of healthcare systems and health insurance policies, increasing access to drugs; and the emergence of middle classes with disposable incomes, who are more likely to spend money on branded generics and branded pharmaceuticals.

Your key questions answered

* Evaluate the evolving prescription pharmaceutical landscape and how this is set to impact Pharma out to 2015

* Quantify the size and growth of the 12 major pharmaceutical markets, analyzing key therapy areas, brands and companies

* Assess drivers and resistors of the prescription pharmaceutical market

Executive Summary

Introduction

Strategic scoping and focus

Key Findings

Pharmaceutical market size in the 12 major markets

Leading therapy areas in the 12 major markets

Leading prescription pharmaceutical brands in the 12 major markets

Leading pharmaceutical companies in the 12 major markets

Global drivers and resistors for sales growth of the leading pharmaceutical companies out to 2015

Related reports

Upcoming related reports

2. HISTORICAL PRESCRIPTION PHARMACEUTICAL SALES ANALYSIS

Pharmaceutical Market Size

The US pharmaceutical market while the largest will decline through 2015

Cost-containment policies throughout Europe translate in modest growth

Brand loyal Japan aims to boost its generics industry

Australia's small pharmaceutical market is also undertaking cost-cutting measures

The emerging markets showed the fastest growth rates

Leading Therapy Areas

The CNS and cardiovascular markets will experience sales declines out to 2015 due to increasing generic competition

Metabolic, oncology and oncology markets driven by biologic sales growth

Chinese medicines are the fastest growing drug group

Leading Pharmaceutical Brands

Lipitor is to experience a dramatic loss in sales due to its looming patent expiry

Plavix is the industry-leading antithrombotic and is supported by a wealth of post-launch data

Nexium growth is attributed to its gold standard status and extensive patient switching, but sales are forecast to decline

Leading Pharmaceutical Companies

Pfizer

Merck & Co.

AstraZeneca

GlaxoSmithKline

Novartis

Sanofi-Aventis

Roche

Johnson & Johnson

Eli Lilly

Takeda

3. FORECAST PRESCRIPTION PHARMACEUTICAL SALES ANALYSIS

Definitions

Global drivers and resistors for sales growth of the top 50 pharmaceutical companies out to 2015

The top 50 pharmaceutical companies (excluding generics companies) will experience sales growth of only 1.1% per year out to 2015

Expiries will only just be offset by newly launched and core drugs

The pharmaceutical industry's biologic focus is growing

The industry will derive the majority of its sales from external products by 2015

Growth in global markets will more than offset sales decline in the US

Secondary care therapy areas are becoming a priority for pharma

Injectable drugs are set to drive market growth

Blockbuster drug sales will decline during 2010–15

4. BIBLIOGRAPHY

Publications and online articles

Datamonitor reports and products

APPENDIX

Datamonitor prescription pharmaceutical definition and therapy area classification

To order this report:

: Pharmaceutical Key Trends 2011 - Prescription Pharmaceutical Sales Overview

More  Market Research Report

Check our  Company Profile, SWOT and Revenue Analysis!

Nicolas Bombourg

Reportlinker

Email: nbo@reportlinker.com

US: (805)652-2626

Intl: +1 805-652-2626


'/>"/>
SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Reportlinker Adds Pharmaceutical Key Trends 2011 - Healthcare System and Drug Regulatory Overview: Cost-containment and regulatory pressures intensify
2. Reportlinker Adds Pharmaceutical Key Trends 2011 - Biosimilar Market Overview
3. Reportlinker Adds Pharmaceutical Key Trends 2011 - Brand Erosion Post-Patent Expiry
4. Reportlinker Adds Forecast Insight: Antibacterials
5. Reportlinker Adds Global Cardiovascular Surgery Devices Market Trends and Future Forecast (2009 - 2014)
6. Reportlinker Adds European Smart Homes and Assisted Living Market (2010-2015)
7. Reportlinker Adds The Outlook for Pharmaceuticals in Latin America
8. Reportlinker Adds Global Respiratory Care Devices Market (2010 - 2015)
9. Reportlinker Adds Orphan Drugs in Asia: Guidelines and Regulatory Requirements to Help Orphan Drug Products Enter the Asian Market 2011
10. Reportlinker Adds Epidemiology: Sepsis
11. Reportlinker Adds Cancer Vaccines Markets
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... 2016 Any dentist who has made an implant ... process. Many of them do not even offer this as ... high laboratory costs involved. And those who ARE able to ... a high cost that the majority of today,s patients would ... Parsa Zadeh , founder of Dental Evolutions Inc. and inventor ...
(Date:6/23/2016)... LOS ANGELES , June 23, 2016 /PRNewswire/ ... (NASDAQ: CAPR ), a biotechnology company ... first-in-class therapeutics, today announced that patient enrollment in ... progrEssion in Duchenne) has exceeded 50% of its ... its enrollment in the third quarter of 2016, ...
(Date:6/23/2016)... 2016  Astellas today announced the establishment of Astellas Farma Colombia (AFC), a new affiliate with operations headquartered in ... America . ... ... ... ...
Breaking Medicine Technology:
(Date:6/26/2016)... ... ... PawPaws brand pet supplements owned by Whole Health Supply is ... of felines. The formula is all-natural and is made from Chinese herbs that have ... Kidney Support Supplement Soft Chews are Astragalus Root Extract and Rehmannia Root Extract ...
(Date:6/25/2016)... ... 2016 , ... Experts from the American Institutes for Research ... June 26-28, 2016, at the Hynes Convention Center in Boston. , AIR experts ... planning, healthcare costs and patient and family engagement. , AIR researchers will be ...
(Date:6/25/2016)... Viejo, California (PRWEB) , ... June 25, 2016 , ... ... to fit their specific project," said Christina Austin - CEO of Pixel Film Studios. ... fully customizable and all within Final Cut Pro X . Simply select a ...
(Date:6/25/2016)... , ... June 25, 2016 , ... ... and non-athletes recover from injury. Recently, he has implemented orthobiologic procedures as a ... area —Johnson is one of the first doctors to perform the treatment. Orthobiologics ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published June ... with. The article goes on to state that individuals are now more comfortable seeking ... common operations such as calf and cheek reduction. The Los Angeles area medical group, ...
Breaking Medicine News(10 mins):